Members in the Media
From: Science

Some scientists hate NIH’s new definition of a clinical trial. Here’s why

Science:

Nancy Kanwisher, a cognitive neuroscientist, has spent her career pinning down how the human brain responds to visual inputs such as faces. As part of that work, Kanwisher asks volunteers—usually college students at the Massachusetts Institute of Technology (MIT) in Cambridge, where she works—to lie in an MRI machine that records their brain activity while they do a task, such as viewing a photo. Although such studies reveal information that can be relevant to diseases such as autism, they do not test treatments.

But a few weeks ago, Kanwisher and colleagues in related behavioral research fields—from cognitive psychology to vision science—were dismayed to learn that the U.S. National Institutes of Health (NIH) in Bethesda, Maryland, could soon deem their studies to be clinical trials. That designation would impose a raft of new requirements on studies that have already passed ethics review, such as following different standards for funding applications, and reporting results on clinicaltrials.gov, a public database.

Read the whole story: Science

More of our Members in the Media >


APS regularly opens certain online articles for discussion on our website. Effective February 2021, you must be a logged-in APS member to post comments. By posting a comment, you agree to our Community Guidelines and the display of your profile information, including your name and affiliation. Any opinions, findings, conclusions, or recommendations present in article comments are those of the writers and do not necessarily reflect the views of APS or the article’s author. For more information, please see our Community Guidelines.

Please login with your APS account to comment.